Causalgia

G6_CAUSALGIA

causalgia: Complex regional pain syndrome type 2 (CRPS2), or causalgia is a form of complex regional pain syndrome that develops after damage to a peripheral nerve and is characterized by spontaneous pain, allodynia and hyperalgesia , not necessarily limited to the territory of the injured nerve, as well as at some point, edema, changes in skin blood flow or sudomotor dysfunction in the pain area.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G56.4
  • Hospital discharge: ICD-9 3544
  • Cause of death: ICD-10 G56.4
  • Cause of death: ICD-9 3544

2 out of 7 registries used, show all original rules.

634

4. Check minimum number of events

None

634

5. Include endpoints

None

634

6. Filter based on genotype QC (FinnGen only)

634

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G56
Name in latin
Causalgia

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4108 2491 1591
Only index persons 3917 2418 1499
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.04
Only index persons 0.08 0.09 0.06
Median age at first event (years)
Whole population 47.72 47.94 47.37
Only index persons 47.48 47.68 47.16

-FinnGen-

Key figures

All Female Male
Number of individuals 634 437 197
Unadjusted period prevalence (%) 0.13 0.15 0.09
Median age at first event (years) 46.81 46.03 48.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
558
Matched controls
5581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G56.4
ICD-10 Finland
Causalgia
4503599627370496.0
323.0
537
*
M89.0
ICD-10 Finland
Algoneurodystrophy
206.6
192.8
191
14
N03AX12
ATC
gabapentin; oral
20.2
191.1
329
370
N03AX16
ATC
pregabalin; oral
15.8
180.9
379
658
G56.0
ICD-10 Finland
Carpal tunnel syndrome
34.1
122.7
162
66
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
210.8
116.4
117
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
14.8
116.3
212
221
N06AX21
ATC
duloxetine; oral
12.2
109.8
223
288
N02AX02
ATC
tramadol; systemic, rectal
6.6
91.9
387
1432
N06AA09
ATC
amitriptyline; systemic
9.8
73.9
164
228
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
212.7
73.1
74
*
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
141.8
70.8
74
6
ACC51
NOMESCO Finland
Release of median nerve
196.3
67.7
69
*
N02AA05
ATC
oxycodone; systemic
8.2
67.6
169
282
M79.6
ICD-10 Finland
Pain in limb
4.9
66.2
327
1257
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
41.5
65.7
82
23
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
6.3
56.4
172
369
R52.2
ICD-10 Finland
Other chronic pain
20.0
54.9
84
49
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.7
52.2
173
407
N06AX11
ATC
mirtazapine; oral
4.0
50.1
280
1112
X59
ICD-10 Finland
Exposure to unspecified factor
4.7
47.1
195
576
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
13.5
47.0
84
72
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
24.8
46.6
66
30
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.4
46.1
100
126
G54.0
ICD-10 Finland
Brachial plexus disorders
44.2
45.7
56
14
N03AE01
ATC
clonazepam; systemic
9.3
45.7
100
128
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
45.0
239
885
M25.5
ICD-10 Finland
Pain in joint
3.9
44.7
249
961
N06AX16
ATC
venlafaxine; oral
4.9
44.6
171
463
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
104.8
44.5
48
5
Z01.8
ICD-10 Finland
Other specified special examinations
4.1
43.1
208
702
N03AX09
ATC
lamotrigine; oral
8.7
42.8
97
131
R52.1
ICD-10 Finland
Chronic intractable pain
74.7
42.8
48
7
G56.2
ICD-10 Finland
Lesion of ulnar nerve
46.6
42.1
51
12
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.4
41.6
346
1801
AEA24
NOMESCO Finland
Removal of spinal stimulation elecrode
226.6
41.5
42
*
N07BC02
ATC
methadone; systemic
+∞
40.1
38
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
38.6
229
903
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
6.5
38.6
108
198
X58
ICD-10 Finland
Exposure to other specified factors
4.7
38.6
151
410
TAC99
NOMESCO Finland
Other blockade for chronic pain
110.4
38.3
41
*
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
+∞
36.9
35
*
M54.4
ICD-10 Finland
Lumbago with sciatica
4.1
35.4
163
512
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
35.4
177
599
A01
ICPC
Pain general/multiple sites
6.6
35.2
97
173
N06AA10
ATC
nortriptyline; systemic
17.2
35.1
56
36
WX704
NOMESCO Finland
Intubation
6.1
34.4
101
196
ND1AA
NOMESCO Finland
Wrist X-ray examination
7.4
34.0
85
132
M54.5
ICD-10 Finland
Low back pain
3.2
33.9
251
1142
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.7
31.7
77
114
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.1
31.3
107
247
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
31.1
269
1337
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.3
31.0
103
230
S18
ICPC
Laceration/cut
2.9
30.7
273
1378
R51.80
ICD-10 Finland
Headache
4.0
30.3
140
434
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
25.1
30.1
42
18
M03BX01
ATC
baclofen; systemic
21.6
30.1
44
22
N02BE01
ATC
paracetamol; systemic, rectal
4.5
29.9
512
3972
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.8
29.9
109
269
A02BC05
ATC
esomeprazole; systemic
2.8
29.4
283
1489
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.5
29.2
115
306
WX725
NOMESCO Finland
Noninvasive ventilation
7.9
29.2
69
98
SPAT1153
SPAT
Removal of sutures
3.0
28.7
218
982
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
28.5
272
1415
N05AH04
ATC
quetiapine; oral
3.6
28.3
152
532
AA1AD
NOMESCO Finland
CT of head and brain
3.4
27.9
165
618
N02AJ06
ATC
codeine and paracetamol; systemic
2.8
27.9
269
1400
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
5.9
27.8
82
158
R52.9
ICD-10 Finland
Pain, unspecified
5.3
27.6
90
196
WX702
NOMESCO Finland
Supraglottic ventilation device
6.7
27.4
73
123
M48.0
ICD-10 Finland
Spinal stenosis
5.1
27.1
91
204
L12
ICPC
Hand/finger symptom/complaint
4.0
27.1
119
350
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.0
27.0
48
40
W00
ICD-10 Finland
Fall on same level involving ice and snow
4.3
26.9
109
297
M03BC01
ATC
orphenadrine (citrate); systemic
2.9
25.6
192
843
A02BC03
ATC
lansoprazole; oral
2.9
25.5
202
920
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.8
25.5
90
213
3544A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Causalgia of upper limb
+∞
25.2
24
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
25.2
24
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.4
25.1
80
169
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
9.2
24.9
53
63
H02AB06
ATC
prednisolone; systemic
2.6
24.9
298
1722
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.3
24.7
80
172
N03AF01
ATC
carbamazepine; oral, rectal
6.7
24.3
64
106
AEA20
NOMESCO Finland
Removal of impulse generator of stimulation device in the nervous system
+∞
24.1
23
*
M54.1
ICD-10 Finland
Radiculopathy
9.4
23.9
50
58
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
25.0
23.7
33
14
WX720
NOMESCO Finland
Own respiration
7.4
23.5
57
84
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.7
23.2
83
198
N03AF02
ATC
oxcarbazepine; oral
8.8
23.0
50
62
J01FF01
ATC
clindamycin; systemic
2.7
22.8
198
940
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.6
22.8
114
371
WX002
NOMESCO Finland
Sedation and analgesia
3.1
22.3
145
572
ZXA00
NOMESCO Finland
Right side
2.9
22.1
167
726
M03BX02
ATC
tizanidine; oral
2.5
22.0
401
2816
W19
ICD-10 Finland
Unspecified fall
4.5
21.7
82
207
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
6.2
21.4
59
104
S06.0
ICD-10 Finland
Concussion
3.8
21.0
95
283
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
11.0
21.0
40
39
M01AH05
ATC
etoricoxib; oral
2.4
21.0
377
2592
R4120
NOMESCO Finland
Occupational therapy
5.6
20.9
63
124
A06AD11
ATC
lactulose; oral
3.9
20.9
93
273
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
79.9
20.8
23
*
TAC00
NOMESCO Finland
Peripheral nerve block
79.9
20.8
23
*
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
43.4
20.6
25
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
20.6
185
887
A02BC01
ATC
omeprazole; systemic
2.6
20.6
187
902
R07.4
ICD-10 Finland
Chest pain, unspecified
2.7
20.5
169
770
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.7
20.5
97
300
L86
ICPC
Back syndrome with radiating pain
6.2
20.2
56
99
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.1
20.1
83
227
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
20.1
171
792
M01AE03
ATC
ketoprofen; systemic, rectal
2.4
20.1
247
1395
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.1
19.9
82
224
TAD02
NOMESCO Finland
Sympathetic block of ganglion stellatum
+∞
19.9
19
*
N02AC04
ATC
dextropropoxyphene; oral
9.0
19.8
42
50
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
25.7
19.7
27
11
N05BA01
ATC
diazepam; systemic, rectal
3.4
19.6
106
361
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.9
19.6
85
243
A02BC02
ATC
pantoprazole; systemic
2.3
19.6
379
2652
M01AX01
ATC
nabumetone; oral
7.9
19.6
45
61
N29
ICPC
Neurological sympt/complt other
14.0
19.5
33
25
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.4
19.4
60
122
L11
ICPC
Wrist symptom/complaint
4.5
19.3
72
179
L28
ICPC
Limited function/disability (L)
3.5
19.1
99
328
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.6
19.1
50
82
L17
ICPC
Foot/toe symptom/complaint
2.7
19.0
162
745
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.7
18.9
44
61
AEA27
NOMESCO Finland
Replacement of spinal stimulation electrode
+∞
18.9
18
*
L03
ICPC
Low back symptom/complaint
2.6
18.8
166
782
M79.7
ICD-10 Finland
Fibromyalgia
7.2
18.7
46
69
XA402
NOMESCO Finland
ENMG
12.0
18.7
34
30
M54.2
ICD-10 Finland
Cervicalgia
4.6
18.7
67
160
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
5.9
18.7
53
97
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.1
18.7
37
39
NA1AD
NOMESCO Finland
Cervical spine CT examination
7.1
18.3
45
68
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.5
18.2
92
299
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
16.0
18.2
29
19
ZXA05
NOMESCO Finland
Left side
2.6
18.1
155
712
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
18.1
157
726
C03CA01
ATC
furosemide; systemic
2.8
18.0
134
566
J01DA01
ATC
[U] cefalexin; systemic
2.2
17.8
383
2751
R03AC02
ATC
salbutamol; inhalant
2.2
17.8
329
2208
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.3
17.7
98
340
R06.0
ICD-10 Finland
Dyspnoea
2.6
17.6
151
695
SPAT1301
SPAT
No procedures
2.4
17.6
189
982
SPAT1263
SPAT
Sampling
2.2
17.4
267
1639
M54.3
ICD-10 Finland
Sciatica
4.9
17.4
58
128
R02
ICPC
Shortness of breath/dyspnoea
3.5
17.3
87
281
WX110
NOMESCO Finland
Local anesthesy
2.3
17.1
421
3186
M01AH02
ATC
rofecoxib; oral
3.3
17.0
94
326
M01AB05
ATC
diclofenac; systemic, rectal
2.2
16.9
402
2983
NH1AD
NOMESCO Finland
Ankle and foot CT
8.1
16.9
38
50
A28
ICPC
Limited function/disability NOS
3.5
16.7
83
265
M01AH01
ATC
celecoxib; oral (coxibs)
2.8
16.6
124
522
G44.2
ICD-10 Finland
Tension-type headache
3.0
16.5
104
393
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
5.6
16.5
49
95
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.6
16.4
77
235
L09
ICPC
Arm symptom/complaint
5.9
16.3
46
84
S63.3
ICD-10 Finland
Traumatic rupture of ligament of wrist and carpus
12.2
16.2
29
25
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
4.4
16.2
60
148
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.2
16.2
63
163
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
25.4
16.1
22
9
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
49.0
16.1
19
*
WX400
NOMESCO Finland
Inhalation anesthesy
4.8
16.0
54
121
D07AC01
ATC
betamethasone; topical
2.2
15.9
208
1175
S52.5
ICD-10 Finland
Fracture of lower end of radius
3.5
15.9
77
241
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
15.8
72
214
J01AA02
ATC
doxycycline; systemic
2.4
15.8
455
3623
L16
ICPC
Ankle symptom/complaint
3.5
15.8
79
254
R55
ICD-10 Finland
Syncope and collapse
3.7
15.7
72
216
A02BA02
ATC
ranitidine; systemic
2.7
15.6
121
520
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
15.6
106
420
M47.9
ICD-10 Finland
Spondylosis, unspecified
8.3
15.5
34
43
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
8.3
15.5
34
43
N05CF01
ATC
zopiclone; oral
2.3
15.5
185
997
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
7.0
15.4
38
58
L08
ICPC
Shoulder symptom/complaint
2.6
15.3
122
533
R42
ICD-10 Finland
Dizziness and giddiness
2.6
15.1
131
599
N06AA12
ATC
doxepin; systemic
5.0
15.0
49
106
M77.1
ICD-10 Finland
Lateral epicondylitis
3.9
15.0
64
180
L29
ICPC
Musculoskeletal sympt/complt other
4.1
14.9
59
155
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
58.3
14.9
17
*
G56.3
ICD-10 Finland
Lesion of radial nerve
58.3
14.9
17
*
M01AE02
ATC
naproxen; oral, rectal
2.0
14.7
341
2426
J01DB01
ATC
cefalexin; oral
2.5
14.7
478
3941
WX204
NOMESCO Finland
Axillary plexus blockaced
6.5
14.7
38
62
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
14.6
81
279
J01MA02
ATC
ciprofloxacin; systemic
2.1
14.6
221
1317
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
14.4
197
1126
SPAT1229
SPAT
Assessment of need for aid
4.2
14.4
56
145
S93.4
ICD-10 Finland
Sprain and strain of ankle
3.1
14.4
82
290
F43.1
ICD-10 Finland
Post-traumatic stress disorder
6.5
14.4
37
60
WX290
NOMESCO Finland
Other blockade of nerve
2.0
14.3
287
1917
M02AA07
ATC
piroxicam; topical
2.1
14.3
213
1261
Z50.1
ICD-10 Finland
Other physical therapy
5.0
14.2
46
99
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
5.3
14.1
43
86
R1250
NOMESCO Finland
Evaluation of functional capability
9.2
14.1
29
33
R50.9
ICD-10 Finland
Fever, unspecified
2.9
14.1
93
363
G50.1
ICD-10 Finland
Atypical facial pain
16.3
14.0
22
14
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
14.0
306
2110
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
14.0
87
325
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.7
14.0
48
110
R33
ICD-10 Finland
Retention of urine
4.8
13.8
46
102
L15
ICPC
Knee symptom/complaint
2.4
13.7
132
636
B01AB05
ATC
enoxaparin; parenteral
2.2
13.7
177
979
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
4.6
13.5
47
109
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
4.0
13.4
54
144
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
7.6
13.4
31
43
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
4.8
13.4
45
101
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
4.0
13.3
54
145
SPAT1284
SPAT
Extensive health certificate
7.9
13.3
30
40
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
5.1
13.3
42
88
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
8.2
13.2
29
37
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
13.2
206
1233
M01AX17
ATC
nimesulide; oral
2.3
13.1
145
746
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
13.1
112
505
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.9
13.1
36
64
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
29.1
13.0
17
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
12.9
243
1564
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.2
12.9
40
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
12.8
89
357
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
7.3
12.7
30
43
TQW40
NOMESCO Finland
Remowal of suture of skin
3.5
12.7
60
184
R52.0
ICD-10 Finland
Acute pain
5.4
12.7
38
75
M65.3
ICD-10 Finland
Trigger finger
5.7
12.6
36
67
G56.1
ICD-10 Finland
Other lesions of median nerve
+∞
12.5
12
*
G56.8
ICD-10 Finland
Other mononeuropathies of upper limb
+∞
12.5
12
*
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
13.6
12.5
21
16
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.9
12.4
52
144
R06AE07
ATC
cetirizine; oral
1.9
12.4
271
1839
M24.2
ICD-10 Finland
Disorder of ligament
10.8
12.4
23
22
JAH01
NOMESCO Finland
Laparoscopy
4.1
12.3
48
125
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
12.3
112
522
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
8.0
12.3
27
35
T92.2
ICD-10 Finland
Sequelae of fracture at wrist and hand level
16.3
12.2
19
12
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
12.2
131
662
N06AB04
ATC
citalopram; systemic
2.2
12.2
139
724
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.4
12.2
112
526
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
12.1
70
249
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
11.4
12.1
22
20
C07AB07
ATC
bisoprolol; oral
2.0
12.1
224
1423
EBA00
NOMESCO Finland
Extraction of tooth
2.0
12.1
195
1172
T92.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of upper limb
27.4
12.1
16
6
Z04.3
ICD-10 Finland
Examination and observation following other accident
7.8
12.0
27
36
L99
ICPC
Musculoskeletal disease other
8.7
11.9
25
30
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
10.9
11.9
22
21
C01DA14
ATC
isosorbide mononitrate; oral
3.5
11.8
56
173
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
8.0
11.8
26
34
M01AH03
ATC
valdecoxib; oral
3.5
11.7
55
168
G56.9
ICD-10 Finland
Mononeuropathy of upper limb, unspecified
66.4
11.6
13
*
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
19.4
11.6
17
9
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
23.5
11.6
16
7
R20.2
ICD-10 Finland
Paraesthesia of skin
3.4
11.6
56
175
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
5.3
11.6
35
70
K07.60
ICD-10 Finland
Snapping jaw
4.0
11.6
46
122
SPAT1097
SPAT
Recording of ECG
2.7
11.5
85
353
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
11.5
158
889
N02AA03
ATC
hydromorphone; systemic, rectal
+∞
11.5
11
*
P29
ICPC
Psychological sympt/compl other
4.0
11.5
46
123
N05CF02
ATC
zolpidem; oral
2.2
11.4
126
641
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
11.4
52
155
N01
ICPC
Headache
2.8
11.4
74
285
RF210
NOMESCO Finland
NA
5.7
11.4
32
59
XA800
NOMESCO Finland
Neuropsychological investigation
4.8
11.3
37
81
N06AB06
ATC
sertraline; oral
2.7
11.3
82
335
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.7
11.2
49
141
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
13.1
11.2
19
15
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
11.2
138
740
SPAT1210
SPAT
Application of cast or individual aid
5.0
11.2
35
73
G50.0
ICD-10 Finland
Trigeminal neuralgia
20.5
11.2
16
8
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.0
11.1
166
963
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
11.0
171
1008
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
11.0
327
2426
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
5.9
11.0
30
53
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.7
10.9
27
42
G57.6
ICD-10 Finland
Lesion of plantar nerve
12.2
10.9
19
16
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
4.1
10.8
42
109
J01FA10
ATC
azithromycin; systemic
1.8
10.8
351
2675
G83.4
ICD-10 Finland
Cauda equina syndrome
28.6
10.8
14
5
M79.1
ICD-10 Finland
Myalgia
2.5
10.7
88
388
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.7
10.6
47
137
S01
ICPC
Pain/tenderness of skin
4.6
10.6
36
82
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
8.8
10.6
22
26
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
11.5
10.6
19
17
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
7.5
10.6
24
33
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
10.6
44
122
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
10.5
300
2179
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
10.5
75
305
T92.4
ICD-10 Finland
Sequelae of injury of nerve of upper limb
+∞
10.4
10
*
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
5.5
10.4
30
57
SPAT1254
SPAT
Administration of medicine
2.5
10.4
83
358
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
3.6
10.3
46
135
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
23.9
10.3
14
6
N05AA02
ATC
levomepromazine; systemic
4.3
10.3
37
90
UJF32
NOMESCO Finland
Coloscopy
2.1
10.2
142
796
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.0
10.2
40
105
M70.6
ICD-10 Finland
Trochanteric bursitis
2.7
10.2
74
304
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.5
10.2
47
142
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
10.1
42
116
N05BA04
ATC
oxazepam; oral
2.0
10.1
148
846
N06AX26
ATC
vortioxetine; oral
3.4
10.1
49
154
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.2
10.1
52
171
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.7
10.1
28
51
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
10.0
407
3299
K59.0
ICD-10 Finland
Constipation
4.1
10.0
38
97
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
10.0
75
312
N05CD07
ATC
temazepam; oral
2.7
10.0
69
275
SPAT1058
SPAT
PEF monitoring instruction
3.0
10.0
58
208
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
9.9
62
233
R96
ICPC
Asthma
2.9
9.8
60
220
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
20.5
9.8
14
7
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.6
9.8
44
130
SPAT1262
SPAT
Handing over of treatment supplies
2.3
9.8
101
496
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.8
9.8
62
235
N02AJ13
ATC
tramadol and paracetamol; systemic
7.6
9.8
22
30
R09
ICPC
Sinus symptom/complaint
3.0
9.8
58
211
WX203
NOMESCO Finland
Infraclavicular plexus blockade
7.0
9.7
23
34
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
7.0
9.7
23
34
XFE00
NOMESCO Finland
Epicardial ultrasonography
7.3
9.6
22
31
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
9.3
9.6
19
21
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.7
9.6
69
280
M01AC06
ATC
meloxicam; systemic, rectal
1.8
9.4
205
1349
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.9
9.4
38
103
ACC52
NOMESCO Finland
Release of radial nerve
+∞
9.4
9
*
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
9.4
9
*
SPAT1240
SPAT
Therapeutic discussion
2.5
9.4
75
325
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
9.4
77
338
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
6.6
9.3
23
36
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
10.9
9.3
17
16
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
9.3
134
760
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.6
9.3
26
48
WX200
NOMESCO Finland
Interscalenous plexus blockade
7.5
9.3
21
29
J45.1
ICD-10 Finland
Nonallergic asthma
3.2
9.3
48
159
TAB20
NOMESCO Finland
Epidural puncture
14.0
9.2
15
11
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.1
9.2
121
663
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
6.4
9.2
23
37
D07AD01
ATC
clobetasol; topical
2.2
9.1
95
469
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
9.1
107
559
UKC02
NOMESCO Finland
Cystoscopy
2.4
9.1
76
338
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.3
9.1
85
398
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
9.1
67
278
Y86
ICD-10 Finland
Sequelae of other accidents
37.3
9.0
11
*
WX308
NOMESCO Finland
Sacral anesthesy
37.3
9.0
11
*
L14
ICPC
Leg/thigh symptom/complaint
3.1
9.0
51
178
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.3
9.0
45
145
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
7.6
9.0
20
27
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
7.6
9.0
20
27
TAB00
NOMESCO Finland
Lumbar puncture
3.6
9.0
39
113
N06AX03
ATC
mianserin; oral
3.7
8.9
38
108
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.2
8.9
46
152
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
8.9
50
173
K04.1
ICD-10 Finland
Necrosis of pulp
2.5
8.9
70
301
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
8.8
42
131
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
8.8
226
1561
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.3
8.8
82
385
R03DC03
ATC
montelukast; oral
2.1
8.8
105
551
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
8.8
68
289
L04
ICPC
Chest symptom/complaint
3.4
8.8
41
126
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
4.5
8.7
30
70
R03AC12
ATC
salmeterol; inhalant
4.5
8.7
30
70
M19.8
ICD-10 Finland
Other specified arthrosis
5.2
8.7
26
52
N03A
ATC
ANTIEPILEPTICS
50.8
8.7
10
*
C02AC01
ATC
clonidine; systemic
50.8
8.7
10
*
N06AB10
ATC
escitalopram; oral
2.0
8.6
130
749
NC2AA
NOMESCO Finland
Forearm X-ray examination
10.3
8.6
16
16
R51.81
ICD-10 Finland
Facial pain NOS
5.5
8.5
24
45
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
28.0
8.5
11
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.6
8.5
28
63
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.5
8.4
67
290
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
6.9
8.4
20
30
M25.2
ICD-10 Finland
Flail joint
8.0
8.4
18
23
C07AB02
ATC
metoprolol; systemic
2.2
8.4
92
463
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
5.4
8.4
24
46
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
4.1
8.4
31
78
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
8.4
53
201
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
8.4
8
*
NCK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of elbow or forearm, other location
+∞
8.4
8
*
N81
ICPC
Injury nervous system other
+∞
8.4
8
*
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
+∞
8.4
8
*
AXX90
NOMESCO Finland
Intravascular test of medication against pain
+∞
8.4
8
*
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
+∞
8.4
8
*
W10
ICD-10 Finland
Fall on and from stairs and steps
3.5
8.3
38
115
-1
NOMESCO Finland
NA
1.8
8.3
201
1354
C10AA01
ATC
simvastatin; oral
1.8
8.3
171
1098
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
8.3
37
110
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
8.3
103
549
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
8.3
70
311
M50.3
ICD-10 Finland
Other cervical disc degeneration
6.6
8.2
20
31
M77.0
ICD-10 Finland
Medial epicondylitis
5.5
8.2
23
43
L81
ICPC
Injury musculoskeletal NOS
7.7
8.2
18
24
WZA90
NOMESCO Finland
Other doctors statement
1.9
8.2
132
776
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.3
8.2
77
360
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.0
8.2
25
52
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
8.1
59
243
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
5.2
8.1
24
48
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
11.9
8.1
14
12
M70.9
ICD-10 Finland
Unspecified soft tissue disorder related to use, overuse and pressure
11.9
8.1
14
12
SPAT1260
SPAT
Consultation of another employee
2.1
8.1
100
531
G51.0
ICD-10 Finland
Bell palsy
33.9
8.1
10
*
C07AA05
ATC
propranolol; systemic
1.9
8.1
123
707
XF404
NOMESCO Finland
Ambulatory ECG
2.7
8.1
54
210
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
8.1
165
1055
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
6.4
8.1
20
32
NH1AI
NOMESCO Finland
Cone beam CT of ankle
22.4
8.0
11
5
L01
ICPC
Neck symptom/complaint
2.2
8.0
79
382
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.8
8.0
50
188
J02AC01
ATC
fluconazole; systemic
1.7
8.0
249
1807
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
8.0
74
347
KMAK
NOMESCO Finland
NA
1.7
8.0
306
2351
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
7.9
66
292
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
4.5
7.9
27
63
G43.9
ICD-10 Finland
Migraine, unspecified
2.8
7.9
51
196
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
6.2
7.9
20
33
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.1
7.9
29
73
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.9
7.9
31
83
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.6
7.9
16
19
A03FA02
ATC
cisapride; oral, rectal
3.1
7.9
44
152
S02
ICPC
Pruritus
5.0
7.8
24
50
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.2
7.8
40
132
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
11.0
7.8
14
13
ND1AD
NOMESCO Finland
Wrist CT examination
9.6
7.8
15
16
D01
ICPC
Abdominal pain/cramps general
2.4
7.8
65
288
A07AA02
ATC
nystatin; oral
3.5
7.8
35
105
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.8
228
1621
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
15.3
7.7
12
8
NHG20
NOMESCO Finland
Fusion of talocrural joint
15.3
7.7
12
8
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.1
7.7
23
47
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.6
7.7
25
56
RF220
NOMESCO Finland
NA
6.8
7.6
18
27
M01AE51
ATC
ibuprofen, combinations; systemic
8.2
7.6
16
20
N06AB03
ATC
fluoxetine; oral
2.2
7.6
79
390
K02.1
ICD-10 Finland
Caries of dentine
1.6
7.6
326
2569
S04
ICPC
Lump/swelling localized
2.6
7.6
53
214
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
25.4
7.6
10
*
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
4.8
7.6
24
52
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.5
7.6
34
102
XG410
NOMESCO Finland
Flow-volume spirometry
3.6
7.5
33
97
R03BA05
ATC
fluticasone; inhalant
2.0
7.5
109
617
WX212
NOMESCO Finland
Femoral plexus blockade
7.3
7.5
17
24
WX892
NOMESCO Finland
Monitored bed care
2.9
7.5
44
160
A03
ICPC
Fever
2.0
7.5
101
555
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
7.5
71
337
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
81.1
7.4
8
*
R01AD09
ATC
mometasone; nasal
1.6
7.4
258
1917
R03BA01
ATC
beclometasone; inhalant
2.1
7.4
83
421
C08CA05
ATC
nifedipine; systemic
3.3
7.4
36
115
M01AB55
ATC
diclofenac, combinations; oral
3.3
7.4
36
115
W17
ICD-10 Finland
Other fall from one level to another
3.7
7.4
31
88
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.8
7.4
146
918
R4110
NOMESCO Finland
Physiotherapy
1.8
7.4
140
869
NDJ64
NOMESCO Finland
Internal fixation of fracture of wrist or hand wire, rod, cerclage or pin
7.0
7.3
17
25
E0000UV
ATC
NA
1.7
7.3
213
1506
J01FA06
ATC
roxithromycin; oral
1.7
7.3
219
1558
TAD08
NOMESCO Finland
Sympathetic block on sacral Level
+∞
7.3
7
*
T92.8
ICD-10 Finland
Sequelae of other specified injuries of upper limb
+∞
7.3
7
*
M67.4
ICD-10 Finland
Ganglion
2.8
7.3
46
174
SPAT1202
SPAT
Intra-articular injection
4.8
7.3
23
50
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
7.3
154
992
S29
ICPC
Skin symptom/complaint other
2.1
7.3
88
461
SPAT1216
SPAT
Assessment of functional ability
2.3
7.3
69
326
L13
ICPC
Hip symptom/complaint
2.1
7.3
82
418
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
7.2
94
509
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
7.2
94
509
M54.6
ICD-10 Finland
Pain in thoracic spine
2.8
7.2
46
175
L02
ICPC
Back symptom/complaint
2.6
7.2
53
220
H01
ICPC
Ear pain/earache
2.3
7.2
69
328
K04.08
ICD-10 Finland
Other specified pulpit
2.7
7.2
47
183
G04CA02
ATC
tamsulosin; oral
2.2
7.2
73
355
S83.2
ICD-10 Finland
Tear of meniscus, current
2.7
7.2
49
194
M01AB08
ATC
etodolac; oral
2.7
7.2
49
194
NDL99
NOMESCO Finland
Other operation on muscle or tendon of wrist or hand
30.4
7.2
9
*
M84.0
ICD-10 Finland
Malunion of fracture
30.4
7.2
9
*
S14.3
ICD-10 Finland
Injury of brachial plexus
30.4
7.2
9
*
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
7.2
135
835
R04
ICPC
Breathing problem other
4.7
7.2
23
51
Z00.0
ICD-10 Finland
General medical examination
2.0
7.2
97
534
J01EA01
ATC
trimethoprim; systemic
1.8
7.2
141
885
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
20.3
7.2
10
5
Y96.8
ICD-10 Finland
Other type of accident
20.3
7.2
10
5
J01MA12
ATC
levofloxacin; systemic
2.0
7.1
89
473
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
7.1
507
4596
R07.3
ICD-10 Finland
Other chest pain
2.5
7.1
55
235
C01CA24
ATC
epinephrine; parenteral
2.7
7.1
48
188
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
7.1
75
374
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
7.0
92
499
H02AB04
ATC
methylprednisolone; systemic
2.0
6.9
86
456
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
6.9
99
555
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
7.7
6.9
15
20
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
14.0
6.9
11
8
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
14.0
6.9
11
8
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.3
6.9
60
273
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
8.4
6.9
14
17
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
5.1
6.9
20
40
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
6.9
60
274
SPAT1310
SPAT
Counselling related to known health issue
1.7
6.9
163
1084
R11
ICD-10 Finland
Nausea and vomiting
2.7
6.9
45
176
P03
ICPC
Feeling depressed
2.4
6.8
56
245
NHG22
NOMESCO Finland
Fusion of subtalar joint
11.1
6.8
12
11
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
6.8
137
866
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
6.2
6.8
17
28
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
6.8
61
279
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
5.8
6.8
18
32
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.8
6.8
18
32
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.6
6.8
29
84
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
6.8
230
1685
EGC10
NOMESCO Finland
Arthroplasty of mandibular joint without graft
40.5
6.8
8
*
NDE40
NOMESCO Finland
Plastic repair of ligament or capsule of wrist with transplant
40.5
6.8
8
*
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
16.9
6.8
10
6
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
16.9
6.8
10
6
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
6.7
30
90
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
5.0
6.7
20
41
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.5
6.7
22
50
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
6.7
211
1516
WW502
NOMESCO Finland
Autotransfusion
22.8
6.7
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
6.7
50
210
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.3
6.7
19
37
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
6.6
6.7
16
25
S80.0
ICD-10 Finland
Contusion of knee
2.8
6.7
42
158
SPAT1211
SPAT
Application of soft bandage
2.5
6.6
49
204
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.9
6.6
39
143
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.6
145
938
R5599
NOMESCO Finland
Other rehabilitation service
4.9
6.6
20
42
RF120
NOMESCO Finland
NA
8.8
6.6
13
15
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
8.8
6.6
13
15
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
2.9
6.6
38
137
SBB10
NOMESCO Finland
Teeth copy
2.8
6.6
40
150
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
6.5
42
162
N03AX11
ATC
topiramate; oral
3.7
6.5
26
72
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.7
6.5
26
72
A04
ICPC
Weakness/tiredness general
2.2
6.5
64
309
A11
ICPC
Chest pain NOS
2.7
6.5
43
170
M19.9
ICD-10 Finland
Arthrosis, unspecified
3.9
6.5
25
67
M19.2
ICD-10 Finland
Other secondary arthrosis
7.5
6.4
14
19
XF402
NOMESCO Finland
ECG with work load test
2.4
6.4
56
252
N03AG01
ATC
valproic acid; systemic, rectal
2.7
6.4
42
164
WX610
NOMESCO Finland
Patient controlled analgesia
14.5
6.4
10
7
NDF25
NOMESCO Finland
Operation for osteochondritis of joint of wrist, arthroscopic
14.5
6.4
10
7
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
14.5
6.4
10
7
A03CA02
ATC
clidinium and psycholeptics; oral
3.1
6.4
33
111
J01FA09
ATC
clarithromycin; systemic
1.6
6.4
179
1243
S63.5
ICD-10 Finland
Sprain and strain of wrist
3.6
6.4
27
78
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
6.4
113
681
H53.2
ICD-10 Finland
Diplopia
4.3
6.4
22
53
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
6.7
6.4
15
23
NBG10
NOMESCO Finland
Acromioplastia
5.3
6.4
18
35
E000006
ATC
NA
2.7
6.4
41
158
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
8.3
6.4
13
16
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.9
6.4
24
63
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
6.3
44
176
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
6.3
295
2324
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
6.3
111
669
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
9.4
6.3
12
13
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.9
6.3
36
128
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.2
6.3
31
101
NCJ62
NOMESCO Finland
Internal fixation of fracture of forearm using plate
4.4
6.3
21
49
N05BA12
ATC
alprazolam; oral
2.2
6.3
61
293
NDL54
NOMESCO Finland
Tenolysis of hand
18.3
6.3
9
5
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
18.3
6.3
9
5
NHF20
NOMESCO Finland
Operation for debridement of ankle joint, open
+∞
6.3
6
*
79199
ICD-8 Finland
Headache
7.1
6.2
14
20
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.2
6.2
30
96
G55.2
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
27.0
6.2
8
*
T92.1
ICD-10 Finland
Sequelae of fracture of arm
27.0
6.2
8
*
G57.0
ICD-10 Finland
Lesion of sciatic nerve
27.0
6.2
8
*
H53.3
ICD-10 Finland
Other disorders of binocular vision
27.0
6.2
8
*
J01CA08
ATC
pivmecillinam; oral
1.6
6.2
228
1692
M01AB51
ATC
indometacin, combinations; oral, rectal
5.1
6.2
18
36
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.6
6.2
20
45
L76
ICPC
Fracture: other
4.6
6.2
20
45
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.4
6.2
17
32
WX402
NOMESCO Finland
General anaesthesia
1.9
6.2
100
585
SPAT1255
SPAT
Intravenous administration of medicine
2.7
6.2
40
155
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.4
6.2
28
86
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.8
6.1
19
41
R01AD08
ATC
fluticasone; nasal
1.7
6.1
163
1110
M01AC01
ATC
piroxicam; systemic, rectal
2.1
6.1
72
372
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.8
6.1
36
132
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
6.1
114
701
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
12.7
6.1
10
8
A46
ICD-10 Finland
Erysipelas
2.1
6.1
66
332
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
6.1
168
1158
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
10.2
6.1
11
11
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
10.2
6.1
11
11
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
6.0
29
93
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
6.0
34
119
R03BA02
ATC
budesonide; inhalant
1.9
6.0
94
546

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3047181) Lactate [Moles/volume] in Blood
83
119
7.87
56.40
5.3
11.3
mmol/l
1.1
1.3
0.86
77
106
(3039000) Anion gap in Blood
62
89
7.61
41.83
5.7
13.1
mmol/l
10.8
11.5
0.94
57
83
(3018572) Chloride [Moles/volume] in Blood
62
89
7.61
41.83
5.8
13.1
mmol/l
104.9
105.1
0.13
57
83
(3032080) INR in Blood by Coagulation assay
331
1695
2.99
40.36
9.0
7.3
inr
1.2
1.1
0.65
75
539
(3013826) Glucose [Moles/volume] in Serum or Plasma
448
2768
3.11
37.70
5.7
4.5
mmol/l
6.6
6.5
0.43
428
2555
(3008152) Bicarbonate [Moles/volume] in Arterial blood
94
226
4.71
36.91
6.9
10.5
mmol/l
25.4
24.7
1.19
88
213
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
271
1304
2.88
36.13
2.4
2.0
u/l
166.7
229.0
0.55
258
1231
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
88
206
4.80
35.66
6.9
14.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
384
2230
2.83
35.41
7.2
6.5
mmol/l
1.2
1.2
0.63
333
1876
(3024561) Albumin [Mass/volume] in Serum or Plasma
347
1923
2.78
34.90
5.7
4.8
g/l
36.2
36.2
0.02
320
1811
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
350
1987
2.70
32.94
5.4
5.7
mmol/l
1.2
1.2
0.34
318
1802
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
193
826
2.92
31.29
4.3
3.2
ng/l
50.6
254.6
2.92
132
572
(3019060) Gas panel - Arterial blood
90
239
4.22
30.93
5.5
7.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
285
1507
2.62
30.34
3.7
2.4
u/l
50.9
56.2
1.61
263
1401
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
71
162
4.81
29.54
5.2
8.8
%
1.9
1.7
0.74
65
154
(3013707) Erythrocyte sedimentation rate by Westergren method
520
3755
3.14
28.35
4.9
3.7
mm/h
11.0
10.5
0.46
498
3480
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
159
4.75
28.34
5.5
8.9
%
1.0
0.9
0.88
64
152
(3016502) Oxygen saturation in Arterial blood
109
376
3.29
25.28
7.1
11.0
%
96.6
96.1
0.55
102
365
(42870588) Differential panel, method unspecified - Blood
283
1605
2.38
24.57
5.1
5.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
105
363
3.27
24.22
7.3
11.2
g/l
126.6
121.8
1.44
99
353
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
116
429
3.09
23.86
6.9
10.2
kpa
5.2
5.1
0.18
110
413
(3027801) Oxygen [Partial pressure] in Arterial blood
116
429
3.09
23.86
6.9
10.2
kpa
11.8
12.6
1.31
110
414
(3003396) Base excess in Arterial blood by calculation
116
430
3.08
23.76
7.0
10.1
mmol/l
2.1
1.2
1.84
95
341
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
385
2518
2.35
23.66
5.1
6.3
umol/l
9.8
10.6
0.69
356
2399
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
518
3879
2.83
23.54
7.8
7.1
u/l
75.2
76.3
0.32
497
3655
(3019150) Specific gravity of Urine by Refractometry
208
1050
2.46
23.21
4.6
3.3
kg/l
1.0
1.0
0.23
47
125
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
217
1143
2.37
21.79
2.0
1.7
mg/l
0.9
1.0
0.59
169
872
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
293
1751
2.25
21.79
3.5
3.3
u/l
32.9
30.8
0.14
283
1662
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
360
2350
2.23
21.39
4.9
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
143
630
2.64
21.03
2.6
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
125
515
2.78
20.96
2.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
148
666
2.59
20.82
1.9
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
445
3237
2.26
19.28
5.7
3.8
e6/l
68.1
887.5
—
8
46
(3026008) Bacteria identified in Urine by Culture
233
1325
2.20
18.99
4.1
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
150
708
2.47
18.91
1.4
1.3
titre
483.3
532.1
0.13
24
139
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
275
1672
2.14
18.86
3.9
3.0
ng/l
22.2
34.3
1.25
166
1008
(3037467) Urinalysis macro (dipstick) panel - Urine
465
3467
2.28
18.61
5.8
3.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
232
1340
2.15
17.98
3.1
3.8
ph
7.4
7.4
0.10
23
253
(3019309) Folate [Moles/volume] in Red Blood Cells
143
692
2.38
16.89
2.0
1.6
nmol/l
1123.7
1221.9
0.75
111
522
(3023368) Bacteria identified in Blood by Culture
200
1114
2.16
16.82
4.1
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
282
1794
2.03
16.54
2.3
1.8
pmol/l
100.3
95.9
0.82
146
889
(3006315) Basophils [#/volume] in Blood
364
2536
2.02
16.50
5.7
5.5
e9/l
0.0
0.0
1.91
325
2225
(3006504) Eosinophils/100 leukocytes in Blood
346
2374
2.01
16.31
5.6
5.7
%
2.9
2.8
0.38
323
2212
(3018677) aPTT in Platelet poor plasma by Coagulation assay
138
667
2.37
16.29
1.9
2.0
s
28.4
29.6
1.65
125
651
(3019069) Monocytes/100 leukocytes in Blood
347
2385
2.00
16.25
5.9
5.9
%
8.3
8.4
0.10
327
2240
(3013115) Eosinophils [#/volume] in Blood
372
2623
2.01
16.17
5.8
5.9
e9/l
0.2
0.2
2.17
338
2333
(3001604) Monocytes [#/volume] in Blood
361
2526
2.00
15.95
5.7
5.5
e9/l
0.6
0.6
0.01
322
2217
(3022096) Basophils/100 leukocytes in Blood
334
2293
1.96
15.40
5.7
5.7
%
0.7
0.7
0.01
312
2137
(3009508) Creatinine [Moles/volume] in Urine
229
1397
2.00
14.72
3.6
3.0
mmol/l
7.7
7.7
0.04
205
1194
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
168
923
2.12
14.32
1.4
1.3
iu/ml
18.2
29.9
0.75
53
302
(3019198) Lymphocytes [#/volume] in Blood
363
2602
1.92
14.32
5.7
5.5
e9/l
2.0
1.9
0.97
330
2323
(3018010) Neutrophils/100 leukocytes in Blood
345
2435
1.91
14.23
5.8
5.5
%
54.5
57.0
4.21
324
2286
(3019550) Sodium [Moles/volume] in Serum or Plasma
610
5397
4.44
13.67
20.3
12.5
mmol/l
139.6
139.7
0.81
605
5256
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
924
2.08
13.59
1.6
1.6
pmol/l
233557473.4
14543545.7
1.05
149
777
(3023103) Potassium [Moles/volume] in Serum or Plasma
611
5417
4.53
13.54
20.3
12.5
mmol/l
4.0
3.9
1.42
605
5260
(3002030) Lymphocytes/100 leukocytes in Blood
345
2460
1.88
13.54
5.8
5.7
%
31.1
28.6
4.74
325
2302
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
466
2.42
13.51
1.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
456
2.42
13.29
1.8
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
48
5.38
12.58
1.9
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
97
447
2.38
12.56
2.3
2.0
nmol/l
353.1
366.2
0.27
89
417
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
179
1057
1.97
12.27
2.3
2.9
ng/l
680.3
784.5
0.23
146
882
(3012516) Albumin [Mass/volume] in Urine
202
1249
1.91
12.03
3.5
3.1
mg/l
1753.3
339.4
1.18
135
793
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
503
4138
2.04
11.95
5.1
4.0
pmol/l
14.4
14.6
1.42
471
3804
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
184
1109
1.93
11.81
2.4
2.0
mg/l
2.4
2.9
2.76
169
956
(3012095) Magnesium [Moles/volume] in Serum or Plasma
133
718
2.08
11.64
2.8
3.5
mmol/l
0.8
0.8
0.19
121
676
(3027923) C peptide [Moles/volume] in Serum or Plasma
18
27
6.83
11.52
1.3
1.7
nmol/l
1.2
1.1
0.11
11
20
(3013650) Neutrophils [#/volume] in Blood by Automated count
390
2976
1.81
11.47
7.8
9.0
e9/l
4.0
4.0
0.05
352
2620
(36660697) Celiac disease serology panel - Serum
86
402
2.32
10.73
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
165
989
1.90
10.62
1.5
1.4
nmol/l
20.9
21.3
0.14
147
848
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
594
5302
2.91
10.46
19.0
11.4
mg/l
18.8
22.1
2.26
528
4058
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
29
74
4.06
10.41
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
46
161
3.00
10.24
3.7
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
290
2082
1.72
10.08
2.8
2.2
nmol/l
74.0
76.1
0.61
268
1911
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
150
886
1.91
10.03
1.4
1.2
u/ml
4.1
13.6
2.00
44
382
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
120
3.30
10.03
1.3
2.2
g/l
9.6
10.2
0.34
27
110
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
132
3.17
9.83
1.3
2.1
g/l
7.3
7.4
0.17
26
104
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
132
3.17
9.83
1.3
2.1
g/l
3.6
3.9
0.98
25
99
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
132
3.17
9.83
1.3
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
122
3.25
9.77
1.2
2.2
g/l
2.9
3.1
0.49
25
101
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
34
105
3.36
9.30
1.2
1.2
mmol/l
3.9
3.7
0.41
28
97
(3020682) Albumin/Creatinine [Ratio] in Urine
199
1323
1.73
8.88
4.2
3.8
mg/mmol
11.1
9.4
0.20
130
832
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
187
1222
1.75
8.86
1.3
1.2
u/ml
1.1
1.9
0.97
31
350
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
100
3.32
8.60
1.7
1.4
—
—
—
0
0
(3015736) pH of Urine
266
1928
1.65
8.50
3.9
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
452
3753
1.71
8.42
3.9
2.9
u/l
53.9
43.3
1.44
428
3549
(3044290) Cell count panel - Cerebral spinal fluid
30
92
3.37
8.31
1.3
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
64
294
2.31
8.29
2.2
2.7
e9/l
72.2
73.8
0.13
49
224
(3020630) Protein [Mass/volume] in Serum or Plasma
65
302
2.28
8.20
1.4
2.3
g/l
66.9
67.8
0.53
59
283
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
105
3.16
7.96
1.2
1.5
e6/l
4.2
3.6
0.10
26
78
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
105
3.16
7.96
1.3
1.6
e6/l
760.5
1148.8
0.13
26
82
(1761868) Lipid panel - Serum or Plasma
151
2229
0.58
7.92
2.6
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
433
3581
1.66
7.91
4.1
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
556
1.95
7.89
6.4
5.8
mmol/l
1.1
1.0
1.52
90
514
(3004588) Protein electrophoresis panel - Serum or Plasma
55
244
2.37
7.71
1.4
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
103
584
1.91
7.66
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
234
2.38
7.51
1.9
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
110
643
1.86
7.44
2.8
2.3
umol/l
12.5
14.0
1.40
101
602
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
548
1.91
7.28
2.4
2.7
umol/l
6.0
6.6
0.14
80
479
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
35
4.66
6.96
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
101
592
1.84
6.75
2.7
2.3
g/l
2.6
2.4
1.65
93
560
(3015377) Calcium [Moles/volume] in Serum or Plasma
221
1603
1.58
6.66
2.7
3.4
mmol/l
2.3
2.4
1.72
198
1437
(3026493) Urate [Moles/volume] in Serum or Plasma
175
1200
1.63
6.66
2.3
2.4
umol/l
316.0
5909.6
4.26
158
1066
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
546
4893
1.83
6.54
6.3
4.6
mu/l
1.7
2.1
0.80
515
4538
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
93
538
1.85
6.47
2.7
2.4
%
22.4
23.7
0.35
56
471
(4010399)
65
334
2.05
6.38
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
67
349
2.03
6.34
3.1
3.7
pmol/l
4.4
4.6
1.02
61
308
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
540
4836
1.79
6.31
6.2
4.8
mmol/mol
40.0
38.8
2.10
512
4542
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
47
3.91
6.30
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
30
4.75
6.24
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
258
1966
1.53
6.12
4.5
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
44
197
2.33
6.07
2.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
66
348
2.00
6.04
2.3
2.8
e9/l
3.8
4.2
0.85
53
288
(3035350) Ketones [Presence] in Urine by Test strip
313
2491
1.51
6.00
4.3
3.1
estimate
0.0
0.0
0.00
38
469
(40761511) CBC panel - Blood by Automated count
605
5654
2.53
5.96
19.3
10.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
167
2.42
5.94
2.2
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
74
409
1.92
5.92
2.1
2.5
%
1.7
1.8
0.40
65
372
(3028707) Methadone [Presence] in Urine by Screen method
27
96
2.89
5.90
3.5
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
317
2539
1.50
5.84
4.3
3.2
estimate
0.0
0.0
0.80
39
457
(3021601) Nitrite [Presence] in Urine by Test strip
314
2511
1.50
5.82
5.9
4.3
estimate
0.0
0.0
0.50
39
474
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
41
3.98
5.74
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
76
3.10
5.70
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
47
3.69
5.51
1.6
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
292
2327
1.47
5.36
3.5
2.7
ug/l
80.4
104.5
2.32
282
2168
(3044941) Cell count panel - Synovial fluid
20
63
3.25
5.36
1.4
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
39
3.92
5.29
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
316
1.96
5.18
1.7
1.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
40
3.82
5.11
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
40
3.82
5.11
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
40
3.82
5.11
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
47
233
2.10
5.10
2.8
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
50
3.47
5.06
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
167
2.29
5.04
1.5
1.9
—
—
—
0
0
(3019225) pH of Specimen
72
416
1.82
5.03
4.3
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
206
1547
1.49
5.03
2.6
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
105
683
1.64
4.81
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
10
20
5.06
4.79
1.1
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
225
2.08
4.78
1.6
2.2
u/l
16491.6
2855.9
—
7
99
(3000850) Epithelial cells [#/volume] in Urine
132
911
1.57
4.74
3.7
2.3
e6/l
8.3
6.6
0.48
120
807
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
153
2.29
4.68
1.4
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
45
228
2.05
4.63
1.2
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
135
2.36
4.59
1.5
1.4
ug/g
275.9
324.0
0.49
14
70
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
21
4.82
4.54
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
39
3.65
4.51
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
39
3.65
4.51
1.1
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
9
12
7.59
4.36
1.4
1.0
nmol/l
248.2
136.0
—
9
7
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
40
3.56
4.35
1.4
2.2
—
—
—
0
0
(3012544) pH of Venous blood
63
367
1.80
4.30
3.7
3.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
56
3.09
4.27
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
56
3.09
4.27
1.6
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
153
2.22
4.25
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
147
1063
1.50
4.23
1.4
1.4
g/l
2.2
2.3
0.47
85
685
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
91
2.58
4.17
1.6
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
161
2.17
4.17
1.5
1.6
iu/ml
0.0
0.0
—
5
23
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
635
0.48
4.17
1.3
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
57
3.04
4.15
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
31
142
2.24
4.12
1.3
2.1
g/l
1.3
1.5
0.70
25
125
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
445
0.39
4.10
1.1
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
156
2.18
4.07
2.3
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
37
3.57
4.07
1.6
1.2
e6/l
35270.0
165186.7
—
5
28
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
605
5750
2.14
4.06
12.3
9.2
u/l
27.6
26.6
0.72
593
5574
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
69
2.81
4.05
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
182
1385
1.44
4.01
2.1
1.6
mmol/l
1.5
1.4
0.81
162
1179
(3022621) pH of Urine by Test strip
52
293
1.84
3.96
3.2
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
557
5174
1.63
3.95
4.8
4.0
mmol/l
6.1
5.8
3.09
529
4789
(4027681)
12
33
3.69
3.94
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
59
2.93
3.92
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
59
2.93
3.92
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
59
2.93
3.92
1.6
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
721
0.52
3.90
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
54
3.01
3.87
1.9
1.3
nmol/l
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
31
147
2.17
3.81
1.1
1.1
—
8.7
—
0
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
109
2.35
3.73
4.0
2.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
162
1223
1.44
3.69
4.1
3.4
%
98.4
95.7
0.71
157
1189
(3011397) Hemoglobin [Presence] in Urine by Test strip
150
1118
1.45
3.66
4.2
3.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
184
2.01
3.66
2.0
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
46
256
1.86
3.65
2.8
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
104
2.36
3.63
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
46
257
1.85
3.61
2.8
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
29
137
2.17
3.61
2.0
2.1
ug/l
565.5
258.8
0.27
29
130
(3040151) Glucose [Moles/volume] in Capillary blood
13
42
3.14
3.38
1.4
7.0
mmol/l
5.1
7.0
—
7
36
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
10
7.06
3.37
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
108
2.27
3.36
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
128
2.16
3.34
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
45
258
1.80
3.27
2.9
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
81
546
1.55
3.21
6.6
6.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
231
1.83
3.16
1.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
324
1.69
3.10
1.7
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
24
112
2.19
3.10
1.8
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
168
1.95
3.05
1.5
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
28
140
2.05
3.05
1.5
1.2
u/ml
2.8
5.5
—
6
31
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
28
140
2.05
3.05
1.5
1.2
u/ml
18.1
1.8
—
6
19
(3027944) Amphetamines [Presence] in Urine
44
257
1.77
3.03
2.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
108
2.17
2.94
1.6
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
101
728
1.46
2.92
2.1
1.7
%
1.6
1.4
1.63
91
647
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
301
0.39
2.88
1.2
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
9
6.72
2.87
4.8
7.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
58
373
1.61
2.82
2.1
2.9
g/l
9.6
10.5
1.02
53
348
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
65
430
1.57
2.81
2.4
2.2
g/l
0.2
0.2
1.97
59
407
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
18
4.49
2.80
1.4
1.0
%
102.5
134.6
—
8
18
(3002032) Base excess in Venous blood by calculation
55
351
1.62
2.76
3.7
3.4
mmol/l
1.8
2.1
0.24
42
286
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
6
8.39
2.75
3.8
8.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
66
2.46
2.73
1.1
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
65
436
1.55
2.65
1.1
1.2
iu/ml
55.9
144.4
3.03
36
192
(3015171) Extractable nuclear Ab [Units/volume] in Serum
38
222
1.76
2.64
1.4
1.2
u/ml
3.0
0.7
—
5
19
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
100
2.14
2.61
1.7
1.2
u/ml
246.4
225.6
0.19
14
66
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
29
156
1.90
2.61
1.9
1.9
ug/l
0.3
2.9
0.91
18
149
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
246
1.71
2.60
3.2
2.7
mmol/l
1.5
1.6
0.07
31
183
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
25
3.64
2.58
1.3
2.1
%
132.2
121.1
—
9
25
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
75
2.30
2.53
1.1
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
154
1223
1.34
2.52
3.9
2.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
39
2.85
2.48
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
39
2.85
2.48
1.3
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
63
2.41
2.48
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
21
3.84
2.47
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
34
2.97
2.42
2.9
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
61
413
1.53
2.40
1.8
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
93
685
1.42
2.40
2.1
2.4
ug/g
228.3
102.5
0.76
73
540
(40768443) Skin Pathology biopsy report
33
191
1.77
2.38
1.2
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
8
6.29
2.37
1.2
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
8
6.29
2.37
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
22
3.67
2.37
1.4
1.4
nmol/l
133.9
158.6
—
8
22
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
84
2.18
2.37
1.1
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
117
899
1.37
2.36
4.9
3.5
%
22.2
21.2
0.30
56
377
(3021901) Oxygen saturation in Capillary blood
16
71
2.29
2.36
1.6
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
147
1171
1.33
2.34
2.8
2.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
25
133
1.92
2.34
5.3
4.7
mmol/l
1.1
1.4
1.59
25
126
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
155
1.84
2.33
1.5
1.9
iu/l
2.8
5.2
1.56
11
61
(3041096) Erythrocytes [Presence] in Urine by Automated
176
1440
1.31
2.32
3.5
2.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
188
0.37
2.30
1.0
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
72
2.25
2.29
1.3
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
41
2.71
2.28
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
41
2.71
2.28
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
86
2.12
2.24
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
9
5.59
2.21
3.8
7.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
36
2.81
2.21
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
149
0.33
2.17
1.0
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
14
4.32
2.15
1.2
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
14
4.32
2.15
1.5
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
14
4.32
2.15
5.0
4.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
110
1.94
2.08
5.9
4.5
mmol/l
3.7
3.8
0.48
21
100
(3009542) Hematocrit [Volume Fraction] of Blood
536
5080
1.36
2.06
20.6
12.2
%
38.5
40.4
3.51
338
3997
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
176
0.39
2.06
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
176
0.39
2.06
1.0
1.4
—
—
—
0
0
(44790047)
13
56
2.35
2.06
1.2
1.8
—
—
—
0
0
(44790049)
13
56
2.35
2.06
1.2
1.8
—
—
—
0
0
(44806118)
13
56
2.35
2.06
1.2
1.8
—
—
—
0
0
(44790048)
13
56
2.35
2.06
1.2
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
177
0.39
2.06
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
177
0.39
2.06
1.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
145
0.34
2.04
1.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1111
1.31
2.03
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
146
0.34
2.03
1.0
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
63
2.25
2.02
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
111
867
1.34
2.02
3.1
2.5
mosm/kgh2o
507.5
538.3
0.80
93
748
(3050129) First trimester maternal screen panel - Serum or Plasma
9
204
0.43
1.98
1.2
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
11
4.57
1.94
1.4
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
5
11
4.57
1.94
1.2
2.3
mmol/l
1.2
1.2
—
5
11
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
45
2.47
1.94
2.6
4.1
—
—
—
0
0
(3020891) Body temperature
26
150
1.76
1.93
4.8
4.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
58
2.27
1.92
1.4
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
93
1.96
1.86
1.9
1.4
u/ml
86.0
110.8
—
6
22
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
311
1.52
1.86
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
17
3.55
1.84
1.3
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
101
1.91
1.82
1.9
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
158
1316
1.27
1.78
4.6
3.5
estimate
0.0
0.0
0.69
40
465
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
136
1112
1.28
1.78
4.1
4.0
ug/l
1.9
2.5
0.80
126
1012
(3002582) Erythrocytes [#/volume] in Urine
162
1356
1.26
1.75
4.2
2.8
e6/l
17.7
118.4
1.32
132
1021
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
95
742
1.33
1.74
1.7
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
24
2.94
1.72
3.1
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
13
3.87
1.72
1.2
1.3
—
—
—
0
0
(4062490)
12
55
2.20
1.68
1.5
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
17
90
1.91
1.66
1.8
2.6
kpa
8.9
8.2
0.88
17
85
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
25
2.82
1.65
2.1
3.1
u/ml
549.9
629.9
—
7
25
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
113
1.79
1.62
1.2
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
14
3.59
1.62
6.8
2.3
—
—
—
0
0
(4024509)
8
32
2.52
1.60
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
57
2.13
1.56
1.8
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
46
326
1.44
1.52
1.9
2.3
ug/l
3.3
7.8
3.60
38
295
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
87
1.86
1.47
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
80
1.90
1.45
1.3
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
80
630
1.31
1.40
1.5
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
67
1.96
1.39
1.3
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
12
60
2.02
1.39
1.9
2.1
mmol/l
1.7
1.6
0.06
12
60
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
75
1.89
1.35
1.9
3.1
—
722.1
—
0
8
(3001019) Free T4 and TSH panel - Serum or Plasma
27
403
0.66
1.35
1.8
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
489
5105
0.82
1.33
13.3
10.3
ml/min/173m2
88.0
86.0
1.18
388
4158
(3013512) EKG study
152
1301
1.22
1.33
4.0
3.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
40
0.00
1.33
0.0
1.3
—
62.5
—
0
6
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
672
0.74
1.28
2.1
2.6
ug/l
0.7
0.7
0.17
37
407
(3029075) Extractable nuclear Ab panel - Serum
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(4035726)
30
433
0.68
1.28
1.3
1.4
—
—
—
0
0
(4306422)
15
84
1.80
1.28
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
73
576
1.30
1.28
5.0
3.9
%
29.9
31.5
0.52
55
395
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
25
2.41
1.24
1.5
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
651
1.28
1.24
1.6
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
15
85
1.78
1.24
1.3
1.4
mmol/l
7.1
7.4
—
8
56
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
56
1.98
1.22
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.22
1.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.22
1.8
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
19
2.64
1.22
1.2
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
117
1.64
1.19
1.2
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
188
1660
1.19
1.18
4.4
3.3
e6/l
36.9
85.8
1.14
145
1119
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
405
1.34
1.17
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
174
1.52
1.17
1.1
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
33
0.00
1.16
0.0
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
44
327
1.37
1.16
8.3
9.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
39
2.06
1.15
2.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
452
1.31
1.13
4.1
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
83
678
1.26
1.12
1.7
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
30
2.35
1.12
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
30
2.35
1.12
1.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
176
1.50
1.12
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
176
1.50
1.12
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
112
1.62
1.10
1.4
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
21
2.39
1.09
1.8
1.0
miu/ml
1272.0
1863.3
—
5
21
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
32
2.20
1.08
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
121
0.49
1.06
2.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
315
1.36
1.06
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
33
2.13
1.06
1.1
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
562
5462
1.25
1.03
5.4
4.4
mmol/l
2.8
2.9
0.59
530
5113
(4198724)
5
22
2.28
1.03
2.8
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
83
1.70
1.02
1.9
2.6
%
18.8
16.5
—
6
46
(3030467) Casts [#/volume] in Urine by Automated count
141
1230
1.19
1.02
4.1
2.8
e6/l
0.5
0.4
0.19
113
901
(3022217) INR in Platelet poor plasma by Coagulation assay
60
479
1.28
0.99
12.6
16.3
inr
1.1
1.2
—
9
74
(40758558) Short blood count panel - Blood
147
1290
1.18
0.99
4.7
6.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
250
1.38
0.98
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
92
1.65
0.98
1.2
1.0
—
13.4
—
0
6
(3052851) Hemolysis interference index of Serum or Plasma
19
124
1.55
0.97
2.9
3.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
182
1.45
0.97
2.0
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
182
1.45
0.97
4.0
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
50
1.81
0.97
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
211
2318
0.87
0.96
8.5
8.5
e9/l
0.0
0.0
0.15
170
1911
(3022145) Colonoscopy Study observation
69
564
1.25
0.95
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
85
1.66
0.95
1.6
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
27
2.23
0.93
1.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
46
360
1.30
0.90
3.1
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
553
5384
1.21
0.87
4.8
4.0
mmol/l
4.8
4.8
0.29
526
5068
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
30
2.01
0.87
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
124
1086
1.18
0.86
1.8
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
141
0.56
0.83
1.5
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
46
1.75
0.82
2.5
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
138
1.46
0.82
1.8
3.9
g/l
0.4
0.3
—
5
58
(3045414) Leukocytes [Presence] in Urine
29
215
1.37
0.82
1.7
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
1.7
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
270
0.69
0.80
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
48
1.68
0.79
1.3
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
235
1.34
0.77
2.7
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
53
1.71
0.75
2.1
2.2
%
87.6
89.6
—
9
53
(3023419) Bacteria identified in Sputum by Culture
9
54
1.68
0.74
3.4
2.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(4268621)
9
56
1.62
0.72
2.2
2.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.1
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.1
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.9
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
29
1.73
0.64
1.2
2.8
%
114.6
102.8
—
5
29
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
29
1.73
0.64
1.4
2.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
211
0.70
0.63
1.5
1.3
miu/ml
95.8
262.2
—
5
102
(1761482) Bacteria [#/volume] in Urine by Culture
6
105
0.57
0.62
1.5
3.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
88
1.49
0.61
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
396
3811
1.10
0.57
3.2
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
98
1.44
0.57
1.6
2.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
5
88
0.56
0.56
4.8
4.7
u/ml
13.6
3252.8
—
5
81
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
450
1.19
0.56
3.1
2.3
u/l
29.2
31.9
0.28
44
379
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
65
1.55
0.55
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
547
5365
1.14
0.53
4.6
4.0
mmol/l
1.4
1.5
4.76
520
5031
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
91
1.44
0.53
2.4
3.6
e9/l
3.9
4.4
0.39
13
91
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
399
1.19
0.51
1.8
2.4
ml/min/173m2
72.1
71.1
0.05
14
152
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
235
1.25
0.49
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
93
1.41
0.48
2.5
4.2
%
55.8
57.1
0.17
13
93
(1616796) Gas panel - Central venous blood
13
94
1.39
0.46
3.6
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
425
0.84
0.44
5.6
3.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
95
1.38
0.44
5.2
4.2
mmol/l
2.9
2.6
0.15
13
64
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
5
31
1.62
0.43
1.4
2.0
%
10.8
12.5
—
5
15
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
122
1.32
0.42
1.8
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
351
1.18
0.42
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
204
2154
0.92
0.41
2.2
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.2
—
6.9
—
0
17
(3047189) Immunofixation for 24 hour Urine
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
60
1.34
0.40
1.4
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
88
1.37
0.40
1.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
88
1.37
0.40
1.1
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.0
—
27.7
—
0
18
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
71
1.41
0.39
2.6
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
35
1.43
0.39
4.6
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
737
1.11
0.37
3.1
2.4
e6/l
1.6
0.9
0.37
48
393
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
70
1.29
0.36
1.7
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
78
0.64
0.36
3.8
2.0
%
73.2
62.1
—
5
78
(4034850)
22
181
1.22
0.35
13.8
7.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
97
895
1.10
0.35
1.6
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
82
1.35
0.34
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
24
200
1.21
0.34
10.9
12.0
mmol/l
24.8
24.5
0.13
24
192
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
91
1.32
0.34
1.7
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
87
0.69
0.33
1.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
128
1.26
0.32
2.4
2.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
92
1.31
0.32
1.2
1.2
u/ml
5.3
7.8
—
6
28
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
474
0.88
0.32
3.9
4.4
ug/l
2.9
23.8
1.24
34
376
(3024928) Oxygen saturation in Venous blood
12
93
1.30
0.30
3.4
2.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
129
0.77
0.28
3.6
2.9
mg/l
1.7
1.5
—
10
117
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
65
1.23
0.27
1.8
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
95
1.27
0.26
1.0
1.0
u/ml
0.3
0.7
—
5
30
(3000330) Specific gravity of Urine by Test strip
24
207
1.17
0.25
2.2
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
75
1.20
0.25
1.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
54
588
0.91
0.24
1.7
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
649
0.92
0.23
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
24
274
0.87
0.23
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
88
1.25
0.22
1.4
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
87
818
1.07
0.22
2.3
2.8
mmol/l
2.4
2.4
0.39
79
729
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
163
1.17
0.21
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
98.9
—
0
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
1.9
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(44813793)
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
397
0.90
0.21
3.3
4.8
%
0.0
0.1
3.61
11
109
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.5
—
66.0
—
0
8
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.5
—
511.7
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
134
0.82
0.21
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
119
1.18
0.18
1.1
1.1
u/ml
0.1
1.6
—
5
42
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.0
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
101
1.19
0.16
1.0
1.0
u/ml
21.4
5.5
—
6
45
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
34
369
0.92
0.15
2.8
3.7
mmol/l
1.2
1.2
0.16
29
314
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
82
1.10
0.15
1.1
1.8
—
—
—
0
0
(3000492) Spirometry study
52
552
0.94
0.14
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
112
1.16
0.14
4.6
2.3
u/ml
0.4
0.3
—
6
54
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
100
0.80
0.13
1.4
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
130
1263
1.04
0.12
3.5
4.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
383
0.94
0.11
3.1
4.5
%
0.7
0.5
0.32
11
90
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
46
1.09
0.09
2.0
1.8
—
7.6
—
0
26
(3035285) Chloride [Moles/volume] in Venous blood
5
47
1.06
0.09
1.4
2.9
mmol/l
105.4
105.2
—
5
47
(3041354) Potassium [Moles/volume] in Venous blood
5
47
1.06
0.09
1.4
2.9
mmol/l
3.8
4.0
—
5
47
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
47
1.06
0.09
1.4
2.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
150
1532
0.97
0.09
1.4
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
97
1.14
0.09
1.4
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
62
0.80
0.08
1.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
64
0.78
0.08
1.0
1.1
g/l
1.5
1.5
—
5
56
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
164
0.91
0.08
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
74
1.08
0.07
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
76
1.05
0.07
1.3
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
710
0.97
0.06
3.2
2.6
e6/l
2.6
3.2
0.17
34
368
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
95
0.84
0.06
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
376
0.95
0.06
3.2
4.9
%
0.0
0.2
1.11
11
97
(3003740) Influenza virus B Ag [Presence] in Specimen
11
120
0.92
0.05
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
120
0.92
0.05
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
41
423
0.97
0.04
3.0
4.6
%
0.8
1.0
0.23
12
124
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
521
5196
1.02
0.03
4.2
3.6
mmol/l
1.5
1.3
2.89
491
4855
(4094501)
14
132
1.06
0.02
1.1
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
65
659
0.98
0.02
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
149
1.01
0.00
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
209
1.00
0.00
1.8
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
112
1122
1.00
0.00
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
319
1.00
0.00
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
95
0.95
0.00
3.0
2.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
54.8
—
0
5
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
0.1
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.0
—
0
7
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
79
0.88
0.00
1.1
1.2
u/l
9.6
30.3
—
7
68
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
55
0.91
0.00
1.0
2.1
pg
30.6
32.5
—
5
55
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
321.0
—
0
5
(44806420)
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(4281824)
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
2.6
—
0
8
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_CAUSALGIA and mortality.

Females

Parameter HR [95% CI] p-value
G6_CAUSALGIA 1.273 [1.05, 1.54] 0.013
Birth year 0.999 [0.99, 1.01] 0.825

During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 2156 females with G6_CAUSALGIA died.

Males

Parameter HR [95% CI] p-value
G6_CAUSALGIA 1.295 [1.08, 1.56] 0.006
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 165 out of 1325 males with G6_CAUSALGIA died.

Mortality risk

Mortality risk for people of age

years, who have G6_CAUSALGIA.

N-year risk Females Males
1 0.137% 0.213%
5 0.811% 1.374%
10 2.068% 3.589%
15 3.917% 6.907%
20 6.745% 11.677%

Relationships between endpoints

Index endpoint: G6_CAUSALGIA – Causalgia

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data